Live from the NIH registry
Studies recruiting near Marysville right now
Top 25 of 204 recruiting studies, sorted by proximity — each links to its official registry page
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Disease
N/A
Observational 35,382 participants sought
Evergreen Health — Kirkland, Washington (27.7 mi)
· Sponsor: Parkinson's Foundation
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 2
Interventional 520 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Atherosclerosis, Cardiovascular Diseases
Phase 3
Interventional 252 participants sought
Eastside Research Associates — Redmond, Washington (28.2 mi)
· Sponsor: Eli Lilly and Company
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Seattle Cancer Care Alliance at EvergreenHealth — Kirkland, Washington (27.7 mi)
· Sponsor: SWOG Cancer Research Network
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Cornerstone P&O — Everett, Washington (7.4 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi)
· Sponsor: NRG Oncology
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Swedish Cancer Institute, Edmonds Campus ( Site 0072) — Edmonds, Washington (21.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Swedish Cancer Institute Edmonds — Edmonds, Washington (21.3 mi)
· Sponsor: Janssen Research & Development, LLC
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Jefferson Healthcare — Port Townsend, Washington (28.0 mi)
· Sponsor: NRG Oncology
Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population
General Health, Wellness
N/A
Observational 20,000 participants sought
Viome Life Sciences — Bothell, Washington (22.1 mi)
· Sponsor: Viome
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
ADHD
Phase 3
Interventional 468 participants sought
Clinical Research Site — Everett, Washington (7.4 mi)
· Sponsor: Axsome Therapeutics, Inc.
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Observational 5,000 participants sought
Virginia Mason Lynnwood Medical Center — Lynnwood, Washington (19.4 mi)
· Sponsor: National Cancer Institute LAO
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Local Institution - 0515 — Edmonds, Washington (21.3 mi)
· Sponsor: Bristol-Myers Squibb
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Bipolar Depression
Phase 3
Interventional 384 participants sought
Core Clinical Research — Everett, Washington (7.4 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Lichen Planopilaris
Phase 2, Phase 3
Interventional 342 participants sought
Clinical Trial Site — Mill Creek, Washington (15.4 mi)
· Sponsor: Priovant Therapeutics, Inc.
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 93 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Parkinson Disease, Parkinson
Phase 2
Interventional 150 participants sought
EvergreenHealth — Kirkland, Washington (27.7 mi)
· Sponsor: Neuron23 Inc.
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Major Depressive Disorder (MDD), Depression in Adults
Phase 3
Interventional 330 participants sought
Core Clinical Research — Everett, Washington (7.4 mi)
· Sponsor: Cybin IRL Limited
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma (MM)
Phase 1
Interventional 258 participants sought
Optum Care Washington — Everett, Washington (7.4 mi)
· Sponsor: Shanghai Henlius Biotech
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi)
· Sponsor: SWOG Cancer Research Network
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
EvergreenHealth — Kirkland, Washington (27.7 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Frontier Dermatology Partners CRO LLC- Site Number : 8400011 — Mill Creek, Washington (15.4 mi)
· Sponsor: Sanofi